ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) gets downgraded to Neutral by Piper Jaffray Companies

ME Staff
-
0

Analyst Ratings For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)

Today, ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock was downgraded by Piper Jaffray Companies from Overweight to Neutral.

There are 8 Buy Ratings, 3 Hold Ratings, no Strong Buy Ratings, no Sell Ratings on the stock.

The current consensus rating on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is Buy with a consensus target price of $50.40 per share, a potential 231.14% upside.

SEE: Market Morning: Economic Menu, Fed’s Bullard Says Remove All Tariffs, Iran Sanctions Tuesday

Some recent analyst ratings include

  • 8/6/2018-Piper Jaffray Companies was Downgraded by analysts at Piper Jaffray Companies from a “Overweight ” rating to a ” Neutral” rating. They now have a N/A price target on the stock.
  • 5/16/2018-HC Wainwright Reiterated Rating of Buy.
  • 11/7/2017-Cowen Reiterated Rating of Buy.
  • 10/12/2017-Jefferies Financial Group Reiterated Rating of Buy.
  • 10/9/2017-Leerink Swann Reiterated Rating of Market Perform.
  • 10/6/2017-Goldman Sachs Group Reiterated Rating of Neutral.

Recent Insider Trading Activity For ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) has insider ownership of 23.28% and institutional ownership of 96.72%.

  • On 3/1/2018 Daniel B Soland, Director, bought 7,000 with an average share price of $23.91 per share and the total transaction amounting to $167,370.00.
  • On 1/29/2018 Glenn Baity, EVP, sold 36,558 with an average share price of $32.39 per share and the total transaction amounting to $1,184,113.62.
  • On 1/2/2018 Glenn Baity, EVP, sold 74,321 with an average share price of $30.14 per share and the total transaction amounting to $2,240,034.94.
  • On 1/2/2018 Laura Brege, Director, sold 25,000 with an average share price of $30.06 per share and the total transaction amounting to $751,500.00.
  • On 10/5/2017 Glenn Baity, EVP, sold 37,500 with an average share price of $40.91 per share and the total transaction amounting to $1,534,125.00.
  • On 8/30/2017 Glenn Baity, EVP, sold 26,507 with an average share price of $34.87 per share and the total transaction amounting to $924,299.09.
  • On 8/9/2017 Glenn Baity, EVP, sold 14,322 with an average share price of $34.88 per share and the total transaction amounting to $499,551.36.